Log In
BCIQ
Print this Print this
 

CLR100

  Manage Alerts
Collapse Summary General Information
Company Clera Inc.
DescriptionSmall molecule dopamine D2 receptor antagonist
Molecular Target Dopamine D2 receptor
Mechanism of ActionDopamine D2 receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationPsychosis
Indication DetailsTreat psychosis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today